Suppr超能文献

相似文献

1
Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters.
JAMA. 2022 Jul 26;328(4):393-395. doi: 10.1001/jama.2022.9734.
2
Presence of banned drugs in dietary supplements following FDA recalls.
JAMA. 2014;312(16):1691-3. doi: 10.1001/jama.2014.10308.
3
Characteristics of FDA drug recalls: A 30-month analysis.
Am J Health Syst Pharm. 2016 Feb 15;73(4):235-40. doi: 10.2146/ajhp150277.
4
Some dietary supplements resemble drugs more than food.
Am J Health Syst Pharm. 2012 May 1;69(9):736-7. doi: 10.2146/news120032.
5
The frequency and characteristics of dietary supplement recalls in the United States.
JAMA Intern Med. 2013 May 27;173(10):926-8. doi: 10.1001/jamainternmed.2013.379.
8
Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019.
Cannabis Cannabinoid Res. 2021 Dec;6(6):559-563. doi: 10.1089/can.2020.0166. Epub 2021 Jun 17.
9
Quantity of phenibut in dietary supplements before and after FDA warnings.
Clin Toxicol (Phila). 2022 Apr;60(4):486-488. doi: 10.1080/15563650.2021.1973020. Epub 2021 Sep 22.

本文引用的文献

2
Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug Administration.
JAMA Intern Med. 2018 Dec 1;178(12):1721-1723. doi: 10.1001/jamainternmed.2018.4846.
3
Presence of banned drugs in dietary supplements following FDA recalls.
JAMA. 2014;312(16):1691-3. doi: 10.1001/jama.2014.10308.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验